DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Elokdah H, Abou-Gharbia M, Hennan JK. et al.
Tiplaxtinin, a novel, orally efficacious inhibitor of plasminogen activator inhibitor-1: design, synthesis, and preclinical characterization.
J Med Chem 2004;
47 (14) 3491-3494
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.